Stock Earnings

Question 1

Harmony Biosciences Holdings Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Harmony Biosciences Holdings Inc의 총 자산은 $999이며, 순profit입니다.

Question 2

HRMY의 주요 재무 비율은 무엇인가요?

Accepted Answer

Harmony Biosciences Holdings Inc의 유동비율은 2.93이고, 순이익률은 20.3, 주당 매출은 $12.33입니다.

Question 3

Harmony Biosciences Holdings Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Harmony Biosciences Holdings Inc largest revenue segment is Rare Neurological Diseases, at a revenue of 714,734,000 in the most earnings release.For geography, United States is the primary market for Harmony Biosciences Holdings Inc, at a revenue of 714,734,000.

Question 4

Harmony Biosciences Holdings Inc은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Harmony Biosciences Holdings Inc의 순profit은 $145입니다.

Question 5

Harmony Biosciences Holdings Inc에 부채가 있나요?

Accepted Answer

yes, Harmony Biosciences Holdings Inc의 부채는 340입니다.

Question 6

Harmony Biosciences Holdings Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Harmony Biosciences Holdings Inc의 총 발행 주식은 57.14주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	825	714	582	437	305	159
Revenue Growth (YoY)	21%	23%	33%	43%	92%	2,550%
Cost of Revenue	184	156	121	83	55	27
Gross Profit	641	557	460	354	249	132
Selling, General & Admin	217	197	168	140	132	95
Research & Development	174	145	76	70	30	19
Operating Expenses	416	367	268	234	162	115
Other Non Operating Income (Expenses)	0	0	0	0	0	-3
Pretax Income	230	191	173	104	37	-36
Income Tax Expense	44	46	44	-76	2	0
Net Income	185	145	128	181	34	-63
Net Income Growth	52%	13%	-28.99%	432%	-154%	-66%
Shares Outstanding (Diluted)	58.71	57.86	60.37	61.1	59.2	56.9
Shares Change (YoY)	1%	-4%	-1%	3%	4%	-11%
EPS (Diluted)	3.17	2.51	2.13	2.97	0.58	-1.12
EPS Growth	50%	18%	-28%	412%	-152%	-62%
Free Cash Flow	296	218	219	104	-1	-3
Free Cash Flow Per Share	5.04	3.76	3.62	1.7	-0.01	-0.05
Gross Margin	77.69%	78.01%	79.03%	81%	81.63%	83.01%
Operating Margin	27.27%	26.61%	32.98%	27.45%	28.52%	10.06%
Profit Margin	22.42%	20.3%	21.99%	41.41%	11.14%	-39.62%
Free Cash Flow Margin	35.87%	30.53%	37.62%	23.79%	-0.32%	-1.88%
EBITDA	248	214	216	143	105	26
EBITDA Margin	30.06%	29.97%	37.11%	32.72%	34.42%	16.35%
D&A For EBITDA	23	24	24	23	18	10
EBIT	225	190	192	120	87	16
EBIT Margin	27.27%	26.61%	32.98%	27.45%	28.52%	10.06%
Effective Tax Rate	19.13%	24.08%	25.43%	-73.07%	5.4%	0%

Harmony Biosciences Holdings Inc (HRMY) Price

HRMY Stock Price Chart

HRMY Income

Follow-Up Questions